Drug Shortage Report for APO-SERTRALINE

Last updated on 2018-01-18 History
Report ID 30967
Drug Identification Number 02238281
Brand name APO-SERTRALINE
Common or Proper name SERTRALINE
Company Name APOTEX INC
Active Ingredient(s) SERTRALINE
Strength(s) 50MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 BTL & 250 BTL
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-11-27
Estimated end date 2018-02-09
Actual end date 2018-01-17
Shortage status Resolved
Updated date 2018-01-18
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2018-01-18 French Compare
v8 2018-01-18 English Compare
v7 2018-01-10 French Compare
v6 2018-01-10 English Compare
v5 2018-01-10 French Compare
v4 2018-01-10 English Compare
v3 2017-11-28 French Compare
v2 2017-11-28 English Compare
v1 2017-11-28 English Compare